InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
T+90 hit rate
29%
T+90 mean return
-17.5%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Donegan Michael C, Cadre Supérieur et Responsable Financier. Director active across 1 company, notably TherapeuticsMD, Inc.. In total, 8 filings have been published. Activity tracked since 6 December 2022. The latest transaction was filed on 12 April 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
50,000 shares0Common StockSEC:0001209191-23-024386:0
2,400 shares0Common StockSEC:0001209191-23-005554:0
380 shares0Common StockSEC:0001209191-23-004871:0
2,300 shares0Common StockSEC:0001209191-22-060585:0
115,000 sharesCommon StockSEC:0001209191-21-067391
115,000 sharesCommon StockSEC:0001209191-21-067391:0
19,000 sharesCommon StockSEC:0001387131-21-005571:0
19,000 sharesCommon StockSEC:0001387131-21-005571
8 of 8 declarations
About Donegan Michael C
Michael C. Donegan is the Chief Administrative Officer and Vice President of Finance at TherapeuticsMD, Inc. He is responsible for managing the financial and administrative operations of the company. His role is essential in ensuring financial health and organizational efficiency.
